10 20 30 40 50 60 70 80 1FQ4 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER HYDROLASE/HYDROLASE INHIBITOR 03-SEP-00 1FQ4
TITLE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN HYDROXYETHYLENE INHIBITOR CP- TITLE 2 108,420 AND YEAST ASPARTIC PROTEINASE A
CAVEAT 1FQ4 CHIRALITY ERROR AT CA CENTER OF 160, 241.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: SACCHAROPEPSIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTATE PROTEASE, PROTEINASE A; COMPND 5 EC: 3.4.23.25
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SACCHAROMYCES CEREVISIAE; SOURCE 3 ORGANISM_COMMON: BAKER'S YEAST; SOURCE 4 ORGANISM_TAXID: 4932
KEYWDS ASPARTIC PROTEINASE-INHIBITOR COMPLEX, EXTENDED BETA-STRAND KEYWDS 2 (INHIBITOR), HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR N.B.CRONIN,M.O.BADASSO,I.J.TICKLE,T.DREYER,D.J.HOOVER,R.L.ROSATI, AUTHOR 2 C.C.HUMBLET,E.A.LUNNEY,J.B.COOPER
REVDAT 5 13-JUL-11 1FQ4 1 VERSN REVDAT 4 24-FEB-09 1FQ4 1 VERSN REVDAT 3 01-APR-03 1FQ4 1 JRNL REVDAT 2 15-NOV-00 1FQ4 1 JRNL REVDAT 1 20-SEP-00 1FQ4 0
JRNL AUTH N.B.CRONIN,M.O.BADASSO,I.J TICKLE,T.DREYER,D.J.HOOVER, JRNL AUTH 2 R.L.ROSATI,C.C.HUMBLET,E.A.LUNNEY,J.B.COOPER JRNL TITL X-RAY STRUCTURES OF FIVE RENIN INHIBITORS BOUND TO JRNL TITL 2 SACCHAROPEPSIN: EXPLORATION OF ACTIVE-SITE SPECIFICITY. JRNL REF J.MOL.BIOL. V. 303 745 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 11061973 JRNL DOI 10.1006/JMBI.2000.4181
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.F.AGUILAR,N.B.CRONIN,M.BADASSO,T.DREYER,M.P.NEWMAN, REMARK 1 AUTH 2 J.B.COOPER,D.J.HOOVER,S.P.WOOD,M.S.JOHNSON,T.L.BLUNDELL REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE AT 2.4 A RESOLUTION OF REMARK 1 TITL 2 GLYCOSYLATED PROTEINASE A FROM THE LYSOSOME-LIKE VACUOLE OF REMARK 1 TITL 3 SACCHAROMYCES CEREVISIAE REMARK 1 REF J.MOL.BIOL. V. 267 899 1997 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1996.0880
REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : RESTRAIN REMARK 3 AUTHORS : MOSS,DRIESSEN,HANEEF,HOWLIN,HARRIS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 12874 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1030 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 12874 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2528 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 120 REMARK 3 SOLVENT ATOMS : 101 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1FQ4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-00. REMARK 100 THE RCSB ID CODE IS RCSB011807.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.5 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.01 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (AGROVATA, ROTAVATA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12874 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 15.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, SODIUM ACETATE, PH 5.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.48000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.74000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.74000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 73.48000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 73.48000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 205 OE2 GLU A 205 5675 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 24 C - N - CA ANGL. DEV. = 12.0 DEGREES REMARK 500 PRO A 24 C - N - CD ANGL. DEV. = -13.0 DEGREES REMARK 500 SER A 35 C - N - CA ANGL. DEV. = 15.5 DEGREES REMARK 500 ILE A 128 CB - CG1 - CD1 ANGL. DEV. = -20.3 DEGREES REMARK 500 VAL A 130 CA - CB - CG2 ANGL. DEV. = -9.6 DEGREES REMARK 500 PHE A 153 CG - CD2 - CE2 ANGL. DEV. = -7.1 DEGREES REMARK 500 ASP A 201 C - N - CA ANGL. DEV. = 16.5 DEGREES REMARK 500 LEU A 220 CB - CG - CD1 ANGL. DEV. = 10.5 DEGREES REMARK 500 TRP A 241 N - CA - CB ANGL. DEV. = 11.3 DEGREES REMARK 500 TRP A 241 CA - CB - CG ANGL. DEV. = 13.9 DEGREES REMARK 500 ARG A 252 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 VAL A 278 CA - CB - CG1 ANGL. DEV. = 13.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 39 136.25 -171.10 REMARK 500 GLU A 59 10.08 -60.12 REMARK 500 ASN A 67 -53.53 -138.61 REMARK 500 ASP A 87 -171.09 166.96 REMARK 500 ASP A 131 13.61 54.45 REMARK 500 SER A 159 -77.41 -76.29 REMARK 500 ASP A 159B -155.05 -107.64 REMARK 500 THR A 159C -42.22 -166.75 REMARK 500 ALA A 188 -67.64 -156.02 REMARK 500 LEU A 220 -144.57 -108.64 REMARK 500 LYS A 239 87.69 -64.39 REMARK 500 TRP A 241 -40.71 -26.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN A 26 24.6 L L OUTSIDE RANGE REMARK 500 LYS A 132 22.9 L L OUTSIDE RANGE REMARK 500 GLU A 160 -14.2 L D WRONG HAND REMARK 500 ASN A 161 24.9 L L OUTSIDE RANGE REMARK 500 LEU A 223 23.6 L L OUTSIDE RANGE REMARK 500 TRP A 241 -0.5 L D EXPECTING SP3 REMARK 500 ILE A 269 23.4 L L OUTSIDE RANGE REMARK 500 TYR A 274 24.9 L L OUTSIDE RANGE REMARK 500 VAL A 278 22.6 L L OUTSIDE RANGE REMARK 500 LEU A 306 18.9 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 525 DISTANCE = 5.23 ANGSTROMS REMARK 525 HOH A 538 DISTANCE = 5.16 ANGSTROMS REMARK 525 HOH A 655 DISTANCE = 5.17 ANGSTROMS REMARK 525 HOH A 675 DISTANCE = 5.67 ANGSTROMS REMARK 525 HOH A 696 DISTANCE = 5.17 ANGSTROMS REMARK 525 HOH A 700 DISTANCE = 5.45 ANGSTROMS REMARK 525 HOH A 701 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH A 702 DISTANCE = 6.07 ANGSTROMS REMARK 525 HOH A 704 DISTANCE = 5.51 ANGSTROMS REMARK 525 HOH A 708 DISTANCE = 5.63 ANGSTROMS REMARK 525 HOH A 709 DISTANCE = 5.02 ANGSTROMS
REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-[(2R)-1-{[(2S,3R,5R)-1-CYCLOHEXYL-3-HYDROXY-5-{ REMARK 630 [2-(MORPHOLIN-4-YL)ETHYL]CARBAMOYL}OCT-7-YN-2-YL]AMINO}-3- REMARK 630 (METHYLSULFANYL)-1-OXOPROPAN-2-YL]-1H-BENZIMIDAZOLE-2-CARBOXAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 2Y2 A 338 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: TRM SMC PCE EMR REMARK 630 DETAILS: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 332 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 333 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMA A 334 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMA A 335 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BGC A 336 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2Y2 A 338 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDG A 337
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2JXR RELATED DB: PDB REMARK 900 RELATED ID: 1DPJ RELATED DB: PDB REMARK 900 RELATED ID: 1FQ5 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH PD-129,541. REMARK 900 RELATED ID: 1FQ6 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH PD-133,450. REMARK 900 RELATED ID: 1FQ7 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH CP-72,647. REMARK 900 RELATED ID: 1FQ8 RELATED DB: PDB REMARK 900 YEAST SACCHAROPEPSIN COMPLEXED WITH CP-81,198.
DBREF 1FQ4 A 0 326 UNP P07267 CARP_YEAST 77 405
SEQADV 1FQ4 ILE A 315 UNP P07267 LEU 394 CONFLICT
SEQRES 1 A 329 GLY GLY HIS ASP VAL PRO LEU THR ASN TYR LEU ASN ALA SEQRES 2 A 329 GLN TYR TYR THR ASP ILE THR LEU GLY THR PRO PRO GLN SEQRES 3 A 329 ASN PHE LYS VAL ILE LEU ASP THR GLY SER SER ASN LEU SEQRES 4 A 329 TRP VAL PRO SER ASN GLU CYS GLY SER LEU ALA CYS PHE SEQRES 5 A 329 LEU HIS SER LYS TYR ASP HIS GLU ALA SER SER SER TYR SEQRES 6 A 329 LYS ALA ASN GLY THR GLU PHE ALA ILE GLN TYR GLY THR SEQRES 7 A 329 GLY SER LEU GLU GLY TYR ILE SER GLN ASP THR LEU SER SEQRES 8 A 329 ILE GLY ASP LEU THR ILE PRO LYS GLN ASP PHE ALA GLU SEQRES 9 A 329 ALA THR SER GLU PRO GLY LEU THR PHE ALA PHE GLY LYS SEQRES 10 A 329 PHE ASP GLY ILE LEU GLY LEU GLY TYR ASP THR ILE SER SEQRES 11 A 329 VAL ASP LYS VAL VAL PRO PRO PHE TYR ASN ALA ILE GLN SEQRES 12 A 329 GLN ASP LEU LEU ASP GLU LYS ARG PHE ALA PHE TYR LEU SEQRES 13 A 329 GLY ASP THR SER LYS ASP THR GLU ASN GLY GLY GLU ALA SEQRES 14 A 329 THR PHE GLY GLY ILE ASP GLU SER LYS PHE LYS GLY ASP SEQRES 15 A 329 ILE THR TRP LEU PRO VAL ARG ARG LYS ALA TYR TRP GLU SEQRES 16 A 329 VAL LYS PHE GLU GLY ILE GLY LEU GLY ASP GLU TYR ALA SEQRES 17 A 329 GLU LEU GLU SER HIS GLY ALA ALA ILE ASP THR GLY THR SEQRES 18 A 329 SER LEU ILE THR LEU PRO SER GLY LEU ALA GLU MET ILE SEQRES 19 A 329 ASN ALA GLU ILE GLY ALA LYS LYS GLY TRP THR GLY GLN SEQRES 20 A 329 TYR THR LEU ASP CYS ASN THR ARG ASP ASN LEU PRO ASP SEQRES 21 A 329 LEU ILE PHE ASN PHE ASN GLY TYR ASN PHE THR ILE GLY SEQRES 22 A 329 PRO TYR ASP TYR THR LEU GLU VAL SER GLY SER CYS ILE SEQRES 23 A 329 SER ALA ILE THR PRO MET ASP PHE PRO GLU PRO VAL GLY SEQRES 24 A 329 PRO LEU ALA ILE VAL GLY ASP ALA PHE LEU ARG LYS TYR SEQRES 25 A 329 TYR SER ILE TYR ASP ILE GLY ASN ASN ALA VAL GLY LEU SEQRES 26 A 329 ALA LYS ALA ILE
MODRES 1FQ4 ASN A 67 ASN GLYCOSYLATION SITE MODRES 1FQ4 ASN A 266 ASN GLYCOSYLATION SITE
HET NAG A 332 14 HET NAG A 333 14 HET BMA A 334 11 HET BMA A 335 11 HET BGC A 336 11 HET 2Y2 A 338 45 HET NDG A 337 14
HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM BMA BETA-D-MANNOSE HETNAM BGC BETA-D-GLUCOSE HETNAM 2Y2 N-[(2R)-1-{[(2S,3R,5R)-1-CYCLOHEXYL-3-HYDROXY-5-{[2- HETNAM 2 2Y2 (MORPHOLIN-4-YL)ETHYL]CARBAMOYL}OCT-7-YN-2-YL]AMINO}- HETNAM 3 2Y2 3-(METHYLSULFANYL)-1-OXOPROPAN-2-YL]-1H-BENZIMIDAZOLE- HETNAM 4 2Y2 2-CARBOXAMIDE HETNAM NDG 2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
HETSYN 2Y2 CP-108,420
FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 BMA 2(C6 H12 O6) FORMUL 2 BGC C6 H12 O6 FORMUL 3 2Y2 C33 H48 N6 O5 S FORMUL 4 NDG C8 H15 N O6 FORMUL 5 HOH *101(H2 O)
HELIX 1 1 SER A 47 HIS A 53 1 7 HELIX 2 2 ASP A 57 SER A 61 5 5 HELIX 3 3 LEU A 110 GLY A 115 1 6 HELIX 4 4 TYR A 125 VAL A 133 5 9 HELIX 5 5 PRO A 135 GLN A 143 1 9 HELIX 6 6 PRO A 224 GLY A 236 1 13 HELIX 7 7 ASP A 248 LEU A 255 5 8 HELIX 8 8 GLY A 270 TYR A 274 1 5 HELIX 9 9 GLY A 302 ARG A 307 1 6
SHEET 1 A 6 HIS A 2 PRO A 5 0 SHEET 2 A 6 GLY A 163 PHE A 167 -1 O ALA A 165 N VAL A 4 SHEET 3 A 6 ARG A 150 LEU A 155 -1 N ALA A 152 O THR A 166 SHEET 4 A 6 TYR A 309 ASP A 314 -1 O SER A 311 N PHE A 153 SHEET 5 A 6 ALA A 319 ALA A 325 -1 O ALA A 319 N ASP A 314 SHEET 6 A 6 PHE A 175 PRO A 183 -1 N LEU A 182 O VAL A 320 SHEET 1 B 8 THR A 7 TYR A 9 0 SHEET 2 B 8 GLN A 13 LEU A 20 -1 O GLN A 13 N TYR A 9 SHEET 3 B 8 GLN A 25 ASP A 32 -1 O GLN A 25 N LEU A 20 SHEET 4 B 8 GLY A 119 GLY A 122 1 O LEU A 121 N ILE A 30 SHEET 5 B 8 LEU A 38 PRO A 41 -1 N TRP A 39 O ILE A 120 SHEET 6 B 8 PHE A 101 SER A 106 1 O ALA A 104 N VAL A 40 SHEET 7 B 8 SER A 79 SER A 85 -1 N GLU A 81 O THR A 105 SHEET 8 B 8 GLU A 70 GLN A 74 -1 N PHE A 71 O GLY A 82 SHEET 1 C 4 THR A 7 TYR A 9 0 SHEET 2 C 4 GLN A 13 LEU A 20 -1 O GLN A 13 N TYR A 9 SHEET 3 C 4 LEU A 89 ILE A 91 -1 O SER A 90 N THR A 19 SHEET 4 C 4 LEU A 94 ILE A 96 -1 O ILE A 96 N LEU A 89 SHEET 1 D 4 GLU A 202 GLU A 205 0 SHEET 2 D 4 GLU A 191 LEU A 199 -1 N ILE A 197 O ALA A 204 SHEET 3 D 4 LEU A 258 PHE A 262 -1 O ASN A 261 N GLY A 196 SHEET 4 D 4 TYR A 265 ILE A 269 -1 O ILE A 269 N LEU A 258 SHEET 1 E 6 GLU A 202 GLU A 205 0 SHEET 2 E 6 GLU A 191 LEU A 199 -1 N ILE A 197 O ALA A 204 SHEET 3 E 6 GLY A 210 ILE A 214 -1 O ALA A 212 N VAL A 192 SHEET 4 E 6 LEU A 298 VAL A 301 1 O ALA A 299 N GLY A 210 SHEET 5 E 6 ILE A 221 LEU A 223 -1 N THR A 222 O ILE A 300 SHEET 6 E 6 ILE A 286 PRO A 288 1 O THR A 287 N ILE A 221 SHEET 1 F 4 LYS A 238 LYS A 239 0 SHEET 2 F 4 TYR A 245 LEU A 247 -1 O THR A 246 N LYS A 238 SHEET 3 F 4 SER A 281 SER A 284 -1 O SER A 284 N TYR A 245 SHEET 4 F 4 THR A 275 VAL A 278 -1 N LEU A 276 O ILE A 283
SSBOND 1 CYS A 45 CYS A 50 1555 1555 2.01 SSBOND 2 CYS A 249 CYS A 282 1555 1555 2.00
LINK O3 BMA A 334 C1 BMA A 335 1555 1555 1.43 LINK O4 NAG A 332 C1 NAG A 333 1555 1555 1.45 LINK O4 NAG A 333 C1 BMA A 334 1555 1555 1.46 LINK ND2 ASN A 67 C1 NAG A 332 1555 1555 1.48 LINK O2 BMA A 335 C1 BGC A 336 1555 1555 1.50 LINK ND2 ASN A 266 C1 NDG A 337 1555 1555 1.45
CISPEP 1 THR A 22 PRO A 23 0 -1.89 CISPEP 2 GLU A 293 PRO A 294 0 4.49 CISPEP 3 GLY A 296 PRO A 297 0 -6.31
SITE 1 AC1 6 ASN A 67 THR A 69 ASP A 100 VAL A 133 SITE 2 AC1 6 NAG A 333 HOH A 524 SITE 1 AC2 4 ASP A 131 LYS A 132 NAG A 332 BMA A 334 SITE 1 AC3 2 NAG A 333 BMA A 335 SITE 1 AC4 5 VAL A 134 TYR A 138 GLN A 142 BMA A 334 SITE 2 AC4 5 BGC A 336 SITE 1 AC5 2 BMA A 335 HOH A 657 SITE 1 AC6 17 GLN A 13 ILE A 30 ASP A 32 GLY A 34 SITE 2 AC6 17 TYR A 75 GLY A 76 THR A 77 THR A 111 SITE 3 AC6 17 PHE A 112 ILE A 128 TYR A 189 ASP A 215 SITE 4 AC6 17 GLY A 217 THR A 218 SER A 219 ILE A 300 SITE 5 AC6 17 HOH A 537 SITE 1 AC7 2 ILE A 259 ASN A 266
CRYST1 86.910 86.910 110.220 90.00 90.00 120.00 P 32 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011506 0.006643 0.000000 0.00000
SCALE2 0.000000 0.013286 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009073 0.00000